Considerations for Expanding Antimicrobial Resistance Surveillance Networks

Clin Infect Dis. 2023 Dec 20;77(Suppl 7):S578-S580. doi: 10.1093/cid/ciad548.

Abstract

Capturing Data on Antimicrobial Resistance Patterns and Trends in Use in Regions of Asia (CAPTURA) gained insight into the range of national antimicrobial resistance (AMR) stakeholders' long-term visions for AMR surveillance networks. As national AMR networks mature, stakeholders often contemplate adding laboratories to the network to achieve greater representativeness, boost data quantity, or meet other goals. Therefore, stakeholders should carefully select laboratories for expansion based on their goals and several practical criteria. Based on CAPTURA experience, the key criteria a national network may consider when expanding its AMR surveillance network include location, laboratory ownership, access to linked clinical and prescription databases, logistical ease, a laboratory's collaborative spirit, laboratory practices and equipment, laboratory staffing and quality assessments, laboratory methods and specimen types, data cleanliness and completeness, and the quantity of AMR data.

Keywords: AMR; Asia; CAPTURA; Expanding AMR surveillance network; surveillance network.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Asia
  • Drug Resistance, Bacterial*
  • Humans
  • Laboratories

Substances

  • Anti-Bacterial Agents